Case Report: Continuous block-and-replace strategy with osilodrostat in a patient with cyclic Cushing’s syndrome - Report - MDSpire

Case Report: Continuous block-and-replace strategy with osilodrostat in a patient with cyclic Cushing’s syndrome

  • By

  • Wiktoria Suchy

  • Mari Minasyan

  • Aleksandra Gamrat-Żmuda

  • Alicja Hubalewska-Dydejczyk

  • Aleksandra Gilis-Januszewska

  • July 9, 2026

  • 0 min

Share

Clinical Report: Implementation of a Continuous Block-and-Replace Approach Using Osilodrostat in a Patient with Cyclic Cushing's Syndrome

Overview

This case study presents a 68-year-old male with cyclic Cushing's syndrome (cCS) who experienced severe fluctuations in cortisol levels leading to recurrent hospitalizations.

Background

Cyclic Cushing's syndrome is characterized by intermittent phases of hypercortisolism and normo/hypocortisolism, complicating diagnosis and management. The unpredictable nature of cCS can lead to life-threatening episodes.

Data Highlights

ParameterValue
ACTHNot suppressed
Cortisol peak34.43-43.5 ug/dl
Cortisol trough8–13 ug/dl
Hypokalemia2.47 mmol/l

Key Findings

  • The patient had a 5-year history of recurrent hospitalizations due to severe infections and metabolic instability.
  • Biochemical tests confirmed ACTH-dependent Cushing's syndrome with dynamic tests suggesting an ectopic origin.
  • Retrospective analysis revealed seven severe episodes of hypercortisolemia separated by spontaneous remissions.
  • Imaging failed to identify the ACTH source, leading to plans for inferior petrosal sinus sampling.

Clinical Implications

This case highlights the challenges in diagnosing cyclic Cushing's syndrome.

Conclusion

This case illustrates the challenges in diagnosing and managing cyclic Cushing's syndrome.

Related Resources & Content

  1. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Once-Daily Administration of Osilodrostat Enhances Cortisol Rhythm, Sleep Quality, and Overall Well-Being in Patients with Cushing's Syndrome
  2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Effectiveness and Safety of Osilodrostat in Nonpituitary Cushing Syndrome: Insights from Real-World Data
  3. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Management Strategies for Patients Experiencing Cyclical Cushing Syndrome
  4. Diagnostic challenges in cyclic Cushing's syndrome: a systematic review - ScienceDirect, 2023
  5. Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome | Endocrine Reviews | Oxford Academic, 2023
  6. Journal of Neuro-Oncology — Strategies for Managing Patients with Persistent Cushing's Disease After Initial Treatment
  7. Diagnostic challenges in cyclic Cushing's syndrome: a systematic review - ScienceDirect
  8. Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome | Endocrine Reviews | Oxford Academic
  9. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase - PubMed

Original Source(s)

Related Content